Table 1.
Description of primary and secondary endpoints.
| Primary endpoint | |
| Maximal value of troponin T (TnT) value during the first 24 h following myocardial reperfusion | |
| Major secondary endpoint | |
| 1 | Maximal value of creatinine kinase isoenzyme muscle-brain (CK-MB) during the first 24 h following myocardial reperfusion |
| Intra-operative related secondary endpoints | |
| 2 | Time between the aortic cross-clamping and the complete cardiac arrest |
| 3 | Percentage of patients requiring catecholamines during aortic cross-clamping |
| 4 | Cumulative dose of catecholamines during aortic cross-clamping |
| 5 | Defibrillation rate after aorta unclamping and coronary reperfusion |
| ICU related secondary endpoints | |
| 6 | Cumulative dose of catecholamines during the first 24 h following coronary reperfusion or until ICU discharge (if discharge occurs before 24 h), starting the calculation at arrival to ICU |
| 7 | Percentage of patients requiring the installation of an IABP during the first 24 h following coronary reperfusion or until ICU discharge (if discharge occurs before 24 h). |
| 8 | Duration of intubation |
| 9 | Duration of ICU stay |
| 10 | Mortality during the first 24 h following coronary reperfusion or until ICU discharge (if discharge occurs before 24 h) |
| 11 | Maximal ST elevation during the first 24 h following coronary reperfusion or until ICU discharge (if discharge occurs before 24 h) |
| Follow-up related secondary endpoints | |
| 12 | Duration of hospitalization. |
| Safety endpoints | |
| 1 | Serious and non-serious adverse events |
| 2 | Laboratory parameters |